Login
From:
ascopost.com
(Uncensored)
subscribe
Revumenib in Triplet Regimen Under Study in Newly Diagnosed AML With NPM1-KMT2A Alterations - The ASCO Post
https://ascopost.com/news/june-2025/revumenib-in-triplet-regimen-under-study-in-newly-diagnosed-aml-with-npm1-kmt2a-alterations/
links
backlinks
Tagged with:
news coverage
clinical research program
joshua zeidner
leukemia clinical program
Roast topics
Find topics
Find it!
A new combination of azacitidine, venetoclax, and revumenib demonstrated high rates of complete response and clinical activity in older adults with newly diagnosed acute myeloid leukemia and an NPM1 m...
